Figures computed from official regulatory filings — .
Analysttarget 2.75 USD (+328%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 36.82% · institutions 19.46% · short 1.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for IRIDEX CORP only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
320 buys206 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Mercer Patrick | Other | $15.1K | SEC |
| Dizon Romeo Rtrack record | Buy | $5K | conv 59Unusual size | SEC |
| Dizon Romeo Rtrack record | Buy | $1.5K | conv 42 | SEC |
| Dizon Romeo Rtrack record | Buy | $3.5K | conv 46 | SEC |
| Dizon Romeo Rtrack record | Buy | $4K | conv 36 | SEC |
| Dizon Romeo Rtrack record | Buy | $973.4 | conv 29 | SEC |
| Dizon Romeo Rtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mercer Patrick | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mercer Patrick | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mercer Patrick | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dizon Romeo Rtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Novel Inspiration International Co., Ltd. | Other | n/a (No price was disclosed in the filing) | SEC |
| Dizon Romeo Rtrack record | Other | $3K | SEC |
| Mercer Patrick | Other | $4.5K | SEC |
| Dizon Romeo Rtrack record | Buy | $1.1K | conv 22 | SEC |
| Dizon Romeo Rtrack record | Buy | $1.9K | conv 22 | SEC |
| Dizon Romeo Rtrack record | Buy | $2.7K | conv 24 | SEC |
| Dizon Romeo Rtrack record | Buy | $2.9K | conv 25 | SEC |
| Dizon Romeo Rtrack record | Buy | $2.8K | conv 24 | SEC |
| Mercer Patrick | Other | $19.4K | Unusual size | SEC |
| Dizon Romeo Rtrack record | Buy | $5K | conv 40 | SEC |
| Novel Inspiration International Co., Ltd. | Other | n/a (No price was disclosed in the filing) | SEC |
| Dizon Romeo Rtrack record | Buy | $1.4K | conv 16 | SEC |
| Dizon Romeo Rtrack record | Buy | $1.4K | conv 16 | SEC |
| Dizon Romeo Rtrack record | Buy | $1.6K | conv 16 | SEC |